TY - JOUR
T1 - Induction of haemolysis and DNA fragmentation in a normal and malarial-infected blood by commonly - used antimalarial drugs in the north-western region of Nigeria
AU - Muhammad, Aliyu
AU - Ibrahim, Mohammed Auwal
AU - Erukainure, Ochuko Lucky
AU - Habila, Nathan
AU - Idowu, Aimola Asegame
AU - Ndidi, Uche Samuel
AU - Malami, Ibrahim
AU - Zailani, Halliru
AU - Kudan, Zeenat Bello
AU - Muhammad, Bilal Abdullahi
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Background: Antimalarial drugs are medicines that are used to prevent or treat malaria effectively at different stages in the life cycle of the malarial parasites. In spite of this, a good number of these drugs have the potential to cause harm when they are misused or abused. Objective: This study was undertaken to evaluate the effects of commonly-used antimalarial drugs in the North Western region of Nigeria on haemolysis and DNA fragmentation in the blood of normal and malarial infected humans ex vivo. Method: The drugs used were artemisinine, artesunate, chloroquine, coartem and quinine (0.5-8.0 mg/ml). Haemolysis, haemoglobin status and DNA fragmentations were assayed for using standard procedures. Results: It was observed that all the drugs induced a remarkable dose-dependent haemolysis with more pronounced effects on apparently healthy humans. There was a significant (P < 0.05) decrease in the level of haemoglobin in normal blood samples when compared with control samples. Contrariwise, in the malaria-infected blood, the haemoglobin level significantly (P < 0.05) increased as compared with control. The drugs caused an exceptional significant (P < 0.05) induction of DNA fragmentation when compared with control. Conclusion: Commonly-used antimalarial drugs induced haemolysis and altered haemoglobin status which may spontaneously increases the cellular iron levels; a substrate for Fenton and Haber Weiss reactions, and eventually induces DNA fragmentation. Hence, adequate care should be taken during prescription with total avoidance for self medications and/or drugs abuse as a result of their adverse effects within the red blood cells and its immediate microenvironment.
AB - Background: Antimalarial drugs are medicines that are used to prevent or treat malaria effectively at different stages in the life cycle of the malarial parasites. In spite of this, a good number of these drugs have the potential to cause harm when they are misused or abused. Objective: This study was undertaken to evaluate the effects of commonly-used antimalarial drugs in the North Western region of Nigeria on haemolysis and DNA fragmentation in the blood of normal and malarial infected humans ex vivo. Method: The drugs used were artemisinine, artesunate, chloroquine, coartem and quinine (0.5-8.0 mg/ml). Haemolysis, haemoglobin status and DNA fragmentations were assayed for using standard procedures. Results: It was observed that all the drugs induced a remarkable dose-dependent haemolysis with more pronounced effects on apparently healthy humans. There was a significant (P < 0.05) decrease in the level of haemoglobin in normal blood samples when compared with control samples. Contrariwise, in the malaria-infected blood, the haemoglobin level significantly (P < 0.05) increased as compared with control. The drugs caused an exceptional significant (P < 0.05) induction of DNA fragmentation when compared with control. Conclusion: Commonly-used antimalarial drugs induced haemolysis and altered haemoglobin status which may spontaneously increases the cellular iron levels; a substrate for Fenton and Haber Weiss reactions, and eventually induces DNA fragmentation. Hence, adequate care should be taken during prescription with total avoidance for self medications and/or drugs abuse as a result of their adverse effects within the red blood cells and its immediate microenvironment.
KW - Antimalarial drugs
KW - DNA damage
KW - Haemoglobin
KW - Haemolysis
KW - Nigeria
UR - http://www.scopus.com/inward/record.url?scp=84959870506&partnerID=8YFLogxK
U2 - 10.2174/187231281001160212150630
DO - 10.2174/187231281001160212150630
M3 - Article
C2 - 26648057
AN - SCOPUS:84959870506
SN - 1872-3128
VL - 10
SP - 49
EP - 55
JO - Drug Metabolism Letters
JF - Drug Metabolism Letters
IS - 1
ER -